GANX
Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.88 / 10
Underperform
Technical rating is Underperform with a 2.88/10 score. Both Long Upper Shadow and Long Lower Shadow appear, providing bearish signals and no bullish cues. The chart suggests weak momentum and heightened downside risk.
Analysis Checks(0/2)
Long Lower Shadow
Score2.69/10
Win Rate46.48%
Hist. Signals71
Avg Return0.44%
Score2.69/10
Win Rate46.48%
Hist. Signals71
Avg Return0.44%
Long Upper Shadow
Score3.08/10
Win Rate50.82%
Hist. Signals61
Avg Return-0.10%
Score3.08/10
Win Rate50.82%
Hist. Signals61
Avg Return-0.10%
Long Lower Shadow
Score2.69/10
Win Rate46.48%
Hist. Signals71
Avg Return0.44%
Score2.69/10
Win Rate46.48%
Hist. Signals71
Avg Return0.44%
Long Upper Shadow
Score3.08/10
Win Rate50.82%
Hist. Signals61
Avg Return-0.10%
Score3.08/10
Win Rate50.82%
Hist. Signals61
Avg Return-0.10%
Technical Analysis of GANX?
- GANX presents a Underperform setup with a Technical Score of 2.88/10. Key technical indicators highlight an RSI of 42.83 and a MACD of -0.09, with the trend anchored by the 50-Day SMA at 2.13. Traders should monitor key support at 1.82 and resistance at 2.01.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
